Cancer News Line

COG Ranks HDVCH PEDs Enrollments in Top 5% of Institutions Nationwide


The teams at CRCWM and Helen DeVos Children’s Hospital (HDVCH) Children’s Oncology Group (COG) are being recognized for their total patient enrollments in 2022.  They were noted as being in the top five percent of all institutions in the nation for both therapeutic and non-therapeutic clinical trials. Congratulations to the teams involved!


CRCWM is recognized in the New England Journal of Medicine for our participation in the SWOG S1801 study.  A huge thanks to Dr. Chen and Dr. Wright for their dedication to this clinical trial and our program.


CRCWM was highlighted by a local news station about our resources available to the community.  


A podcast of oral histories and interviews with the people who have shaped oncology as we know it.
The Cancer History Project is an initiative by The Cancer Letter, oncology's longest-running news publication. The Cancer History Project’s archives are available online at


From the most recent NCI newsletter;

Everyone who takes part in a clinical trial has their own reasons for doing so.  Read some stories of people who participated in clinical trials on this page shared by NCI's Division of Cancer prevention.


From the Recent NCI newsletter;

This page discusses things to consider when you are deciding whether to take part in a clinical trial.


From the most recent NCI newsletter;

Taking part in a cancer treatment clinical trial is a big decision.  This page presents a list of quetions to ask your doctor about before deciding to participate.


Bringing Clinical Trials Closer to Home

Sue Schroder, one of CRCWM's patient advisory committee members, was in the spotlight of the Winter 2021 Cure magazine.  Please click the link above to read the article.


CRCWM was the program in the Spotlight for ECOG-ACRIN the month of July!


It is with great sadness that we tell you of the passing of Patrick "Pat" Gavin, RPh, who died on December 18th after a brief and sudden illness. Pat was the Chair of the CRCWM Patient Advisory Committee and a member of the CRCWM Executive Board. Pat’s passion for the CRCWM mission exemplified the fact that we have “Real Answers, Real Options, Real Miracles….right here in West Michigan,” a vision statement that he helped develop and share with others.

PAB Member (Marty Smith) appointed to the NCI Cancer Prevention Steering Committee


The NCI Cancer Prevention Steering Committee (CPSC) was established on May 25, 2017. The CPSC addresses the design, prioritization and evaluation of concepts for clinical trials to prevent cancer. The CPSC will review innovative cancer prevention, screening and surveillance concepts (i.e., phase 2 and phase 3 randomized trials) across a broad range of cancer and precancerous conditions in diverse patient populations that are seen within the NCI Community Oncology Research Program (NCORP).  Congratulations Marty Smith!

Connie Szczepanek is awarded the NCI's first ever Outstanding Administrator Award


The National Cancer Institute’s first-ever Outstanding Administrator Award in 2017 for her work with the NCI Community Oncology Research Program.

Connie Szczepanek is awared the Michigan Cancer Consortium's Champion of the year, 2017


The MCC Champion Award honors a person who has demonstrated leadership, excellence, success, and impact in the fight against cancer.


CRCWM was the highest accruing site in the United States.  Congratulations to the Cancer control team.

Pat Gavin Goes to Washington DC


Pat Gavin, RPh - Chair of the Patient Advisory Committee for Clinical Research goes to Washington DC to tell his story.


Cure Magazine examines “The Treatment Option You May be Missing” in an extensive look at clinical trials in its summer issue.


Cure’s 16-page guide to clinical trials

Breast Cancer Prevention

To take your breast cancer assessment online (for women 35-84 years old):



Clinical trials offer hope in the fight against cancer !